Notice 7 Apr 2025 energy, infrastructure, artificial intelligence, business development, economic competitiveness, federal land

🏗️DOE RFI on AI Infrastructure Development Opportunities

The United States has long been at the forefront of artificial intelligence (AI) innovation. Maintaining that leadership is a key national and economic security priority. AI infrastructure including data centers is a critical component of the modern economy, enabling AI training and inference, scientific research, and a wide range of other essential services. The U.S. Department of Energy (DOE) is exploring opportunities to leverage its land assets to support the growing demand for AI infrastructure. This aligns with the policy laid out in the executive order signed January 23, 2025, titled "Removing Barriers to American Leadership in Artificial Intelligence," to sustain and enhance America's global AI dominance in order to promote human flourishing, economic competitiveness, and national security.

Learn More
Notice 24 Mar 2025 sec, public meeting, governance, regulation, securities, artificial intelligence, financial industry

🤖SEC Roundtable on Artificial Intelligence in Financial Industry Announced

The SEC has announced a public roundtable focused on artificial intelligence in the financial industry, inviting participation from market participants, academics, and industry professionals to discuss its risks, benefits, and governance. The meeting will be held at the SEC headquarters and is open for public attendance and feedback.

Learn More
Notice 3 Mar 2025 regulation, sec, artificial intelligence, public meeting, investor protection, securities

📅SEC Sunshine Act Meeting Agenda and Public Participation Details

The Securities and Exchange Commission announces a public meeting on March 6, 2025, addressing critical topics like artificial intelligence's operational effects and investor fraud. The public is encouraged to submit written statements, fostering engagement and transparency in regulatory discussions.

Learn More
Notice 6 Feb 2025 technology policy, national science foundation, private sector innovation, executive order, artificial intelligence, ai regulation

🤖Input Request for U.S. AI Action Plan Development

On behalf of the Office of Science and Technology Policy (OSTP), the NITRD NCO requests input from all interested parties on the Development of an Artificial Intelligence (AI) Action Plan ("Plan"). This Plan, as directed by a Presidential Executive Order on January 23, 2025, will define the priority policy actions needed to sustain and enhance America's AI dominance, and to ensure that unnecessarily burdensome requirements do not hamper private sector AI innovation. Through this Request for Information (RFI), OSTP and NITRD NCO seek input from the public, including from academia, industry groups, private sector organizations, state, local, and tribal governments, and any other interested parties, on priority actions that should be included in the Plan.

Learn More
Presidential Document 31 Jan 2025 compliance, regulation, executive order, artificial intelligence, innovation, policy

🤖Executive Order 14179

Executive Order 14179 aims to eliminate barriers to American leadership in artificial intelligence (AI). It emphasizes the nation's commitment to fostering a free and unbiased approach to AI development, asserting that a conducive regulatory environment is essential for sustaining the U.S. position in global AI innovation.

Learn More
Economic Development, Compliance, Employment Initiatives 17 Jan 2025 federal regulations, infrastructure, artificial intelligence, business development, clean energy, job creation, economic competitiveness
Compliance, Regulatory Requirements, Professional Events 15 Jan 2025 business compliance, u.s. department of commerce, export regulations, artificial intelligence, advanced computing

📊Public Briefing on AI Diffusion Framework

On January 10, 2025, the Office of the Federal Register posted for public inspection a Bureau of Industry and Security (BIS) interim final rule: "Framework for Artificial Intelligence Diffusion" (RIN 0694-AJ90). This document announces that, on January 15, 2025, BIS will host a virtual public briefing on this rule. This document also provides details on the procedures for participating in the virtual public briefing.

Learn More
Regulation, Compliance, Technology 15 Jan 2025 business and industry, administrative practice and procedure, reporting and recordkeeping requirements, business compliance, national security, research, exports, terrorism, confidential business information, artificial intelligence, inventions and patents, technology regulation, science and technology, export controls

🤖New Export Controls Impacting AI Technology and Business Compliance

With this interim final rule, the Commerce Department's Bureau of Industry and Security (BIS) revises the Export Administration Regulations' (EAR) controls on advanced computing integrated circuits (ICs) and adds a new control on artificial intelligence (AI) model weights for certain advanced closed-weight dual-use AI models. In conjunction with the expansion of these controls, which BIS has determined are necessary to protect U.S. national security and foreign policy interests, BIS is adding new license exceptions and updating the Data Center Validated End User authorization to facilitate the export, reexport, and transfer (in-country) of advanced computing (ICs) to end users in destinations that do not raise national security or foreign policy concerns. Together, these changes will cultivate secure ecosystems for the responsible diffusion and use of AI and advanced computing ICs.

Learn More
Compliance, Regulatory Guidance 7 Jan 2025 compliance, healthcare, fda, drug regulation, artificial intelligence

🤖FDA Draft Guidance on AI Use in Drug Regulation Available for Comments

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products." In accordance with its mission of protecting, promoting, and advancing public health, FDA's Center for Drug Evaluation and Research (CDER), in collaboration with the Center for Biologics Evaluation and Research (CBER), the Center for Devices and Radiological Health (CDRH), the Center for Veterinary Medicine (CVM), the Oncology Center of Excellence (OCE), the Office of Combination Products (OCP), and the Office of Inspections and Investigations (OII), is issuing this draft guidance to provide recommendations to industry on the use of artificial intelligence (AI) to produce information or data intended to support regulatory decision-making regarding the safety, effectiveness, or quality for drug and biological products.

Learn More